CellaVision AB (publ) announced that Emil Hjalmarsson has been appointed Chairman of the Nomination Committee. The Nomination Committee consists of: Christer Fåhraeus, Christer Fåhraeus with Companies; Nicklas Hansen, William Demant Invest A/S; Anette Andersson, SEB Investment funds and Emil Hjalmarsson, Grenlunden CEVI AB.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237 SEK | +4.41% | +5.10% | +11.79% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.79% | 518M | |
-15.43% | 18.51B | |
-40.81% | 2.85B | |
+19.34% | 1.95B | |
+2.22% | 1.72B | |
+28.27% | 1.26B | |
-9.56% | 1.02B | |
-16.29% | 950M | |
+0.07% | 777M | |
-22.49% | 643M |
- Stock Market
- Equities
- CEVI Stock
- News CellaVision AB
- CellaVision AB Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee